C07D - Heterocyclic compounds

More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)

Patents for C07D - Heterocyclic compounds (10,420)
11/1989
11/02/1989	EP0339022A1 Arylcyclobutenyl amido alkenoic acids and salts thereof
11/01/1989	CN1036770A Cephalosporins derivatives and process for preparation of same
10/1989
10/24/1989	US4876085 Cosmetic composition containing oxathiazinones
10/19/1989	WO1989009772A1 STEREOSPECIFIC METHOD FOR PREPARING ENANTIOMERS OF FURO[3,4-c]PYRIDINE, COMPOUNDS SO OBTAINED AND THERAPEUTIC COMPOSITIONS BASED ON SAID COMPOUNDS
10/18/1989	EP0337858A1 Stereo-specific process for the preparation of enantiomers of furo[3,4-c]pyridine, compounds thus obtained and therapeutical compositions based on these compounds
10/17/1989	US4874856 3-(substituted)propenyl-7-(aminothiazolylacetamido) ceph-3-em-4-carboxylic acids and esters thereof
10/11/1989	CN1036206A Process for preparing azolylmethylsilanes
10/05/1989	DE3901359A1 Cephalosporinsalze und injizierbare mittel Cephalosporinsalze and injectable medium
10/04/1989	EP0335442A2 Agents for preserving or restoring the soundness of the skin
10/03/1989	US4871849 6-fluoro-7-(piperazinyl or 4-methylpiperazinyl) substituted an tibacterial agents; novel 3,4-o-boron derivative intermediates
10/03/1989	US4871390 1-hydroxyethyl-azole compounds and agricultural compositions
09/1989
09/27/1989	EP0334491A1 Thienopyridines, process and intermediates for their preparation and pharmaceutical compositions containing them
09/27/1989	EP0334281A2 Cephalosporin derivatives and process for their preparation
09/26/1989	US4870168 Palladium compound and trifurylphosphine as catalyst
09/26/1989	US4870097 Pharmaceutical use of derivatives of tryptophan
09/26/1989	CA1261322A1 Oxadiazolyl imidabenzodiazepine derivatives, a method of preparing the same, pharmaceutical compositions thereof, and method of treating therewith
09/26/1989	CA1260468A1 Compounds with histamine h.sub.2-receptor antagonistic activities
09/26/1989	CA1260000A1 .alpha. -(PHENOXYALKYLAMINOALKYL)- .alpha. - ALKYLPHENYLACELONITRILES
09/21/1989	WO1989008442A1 Topical preparations
09/19/1989	US4868295 Cephalosporin antibiotic, by-product inhibition
09/13/1989	EP0331983A2 Stilbene derivatives, their preparation and their use in medicines
09/13/1989	EP0331905A1 Process for the preparation of 1,2-disulfones
09/13/1989	CN1035509A Cephalosporins derivatives and process for preparing them
09/13/1989	CN1035508A Process for preparation of new substituted chinoline derivatives
09/13/1989	CN1035500A 芪衍生物 Stilbene derivatives
09/08/1989	WO1989008112A1 Thienopyridines, preparation, intermediates and pharmaceutical compositions
08/1989
08/31/1989	DE3805117A1 Novel azolylmethylsilanes
08/23/1989	EP0329008A2 Cephalosporinderivatives and process for its preparation
08/22/1989	CA1258681A1 2-amino-4-nitro-6-hydroxyalkylanilines; process for preparing the same and their use for dyeing keratinic fibers
08/16/1989	EP0328026A1 Substituted pyrroles
08/08/1989	US4855297 Tricyclic pyridone derivatives
08/08/1989	CA1258233A1 Pharmaceutical compositions for the treatment of involutional brain syndromes and mental decay
07/1989
07/27/1989	WO1989006651A1 1h-indazole-3-acetic acids as aldose reductase inhibitors
07/26/1989	EP0325375A1 1H-indazole-3-acetic acids as aldose reductase inhibitors
07/26/1989	CN1034205A Quinoline derivatives, processes for prepn. thereof and antibacterial agent containing them
07/25/1989	US4851436 HMG-CoA reductase inhibitors
07/19/1989	EP0324347A2 3,5-Dihydroxycarboxylic acids and their derivatives, process for their preparation, their use as medicines, pharmaceutical compositions and intermediates
07/18/1989	CA1257611A1 Dinitro-2,4-hydroxyalkyl-6 anilines, process for their preparation and utilisation as dye for keratinic fibres and specially human hair
07/18/1989	CA1257586A1 .delta. 14,29-15 hydroxy and 14-hydroxy-.delta. 15,16- milbemycin derivatives
07/12/1989	EP0323841A2 Substituted pyrrole, pyrazole and triazole angiotensin II antagonists
07/12/1989	EP0323807A2 Certain 2-substituted adenosine derivatives
07/12/1989	CN1033804A Novel antiarrhythmic agents 1
07/11/1989	US4847373 Coupling a 3-chloromethyl-3-cephems, palladium and phosphine catalysts
07/05/1989	EP0322616A2 Novel 5(and/or 6)substituted 2-(2-imidazolin-2-yl)nicotinic acids, esters and salts, useful as herbicidal agents and nivel intermediates for the preparation of said nicotinic acids, esters and salts
07/04/1989	US4845248 Intermediates for the production of podophyllotoxin
07/04/1989	US4845106 Insecticides
07/04/1989	US4845087 Crystallized cephem-acid addition salts, and a process for the preparation thereof
07/04/1989	CA1256864A1 Oxadiazolylimidazobenzodiazepine, compositions, and method ii
07/04/1989	CA1256863A1 Oxadiazolylimidazobenzodiazepine, compositions, and method i
06/1989
06/29/1989	WO1989005806A1 Novel antiarrhythmic agents iii
06/29/1989	WO1989005795A1 Novel antiarrhythmic agents ii
06/29/1989	WO1989005794A1 Novel antiarrhythmic agents i
06/28/1989	EP0322390A2 Novel antiarrhythmic agents I
06/28/1989	EP0322389A2 Novel antiarrhythmic agents II
06/28/1989	EP0322335A1 New-quanidino-thiazol compounds, their preparation, and use as intermediates of famotidine process
06/28/1989	CN1033521A 2-quanidino-thiazol compounds, their preparation and use as intermediates of famotidine process
06/27/1989	CA1256441A1 Pharmaceutically active derivatives of tryptophan and pharmaceutical compositions containing them
06/20/1989	US4840954 6,7-disubstituted 1-cycloproply-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids
06/20/1989	US4840944 Antibacterial beta-lactams, pharmaceuticals thereof and methods of using them
06/13/1989	CA1255657A1 1,3-disubstituted 2-oxindoles as analgesic and anti- inflammatory agents
06/07/1989	EP0318682A2 Tricyclic thiazole derivatives
06/01/1989	WO1989004830A1 New substituted derivatives of 20,21-dinoreburnamenine, process for preparing them and the new intermediate products so obtained, their application as drugs and the pharmaceutical compositions containing them
05/1989
05/31/1989	EP0317561A1 Sulfonate benzotriazoles and their use in polyamide.
05/30/1989	US4835150 Cephem compounds
05/30/1989	US4834904 Nitrogen-containing heterocycles
05/30/1989	CA1254908A1 2-nitro-4-amino-6-hydroxyalkyl-anilines; process for preparing the same and their use for dyeing keratinic fibers and especially human hair
05/30/1989	CA1254892C Substituted 7-oxomitosanes
05/24/1989	EP0317427A1 Substituted derivatives of 20,21-dinoreburnamenine, process for their preparation and intermediates obtained in this way, their use as medicines, and pharmaceutical compositions containing them
05/24/1989	EP0316967A1 Fluorine-containing nitroimidazole derivatives and radiosensitizer comprising the same
05/24/1989	CN1033051A Azaspiro compounds, their production and use
05/17/1989	EP0315959A2 Quinoxaline compounds and their preparation and use
04/1989
04/26/1989	CN1032540A Cephem compound and process for preparation thereof
04/25/1989	CA1253158A1 1,4-dihydropyridine derivatives; process for preparing the same and their use as therapeutic agents
04/19/1989	EP0311632A1 Surface active lactams.
04/12/1989	EP0310950A1 Quinoline intermediates for the synthesis of 1H-imidazo[4,5-c]quinolines and 1H-imidazo[4,5-c]quinolin-4-amimes
04/11/1989	US4820833 Purification by spray drying precipitation, freeze drying; cephalosporins
04/05/1989	EP0165289B1 Novel derivatives of guanine
04/04/1989	CA1252096A1 Process and intermediates for the preparation of penem derivatives
03/1989
03/29/1989	EP0178980B1 Cephalosporin derivatives, process for their preparation and their antibiotic application
03/22/1989	EP0307804A2 Cephem compound and a process for preparation thereof
03/22/1989	EP0307423A1 Manufacture of haloalkyl lactams
03/21/1989	US4814346 Anticoagulants
03/08/1989	EP0305743A2 Pharmaceutical mixture preparation, its manufacture and use
03/08/1989	EP0305608A1 Biosynthetic 2,5-diketocluconic acid reductase, processes, recombinant cells and expression vectors for its production and its use in preparing 2-keto-L-Gulonic acid
03/08/1989	CN1031534A Process for preparation of 3-exomethylenecepham derivatives
03/07/1989	US4810636 Chromogenic acridinone enzyme substrates
03/01/1989	EP0305111A2 Cephalosporin compounds, process for their preparation and their pharmaceutical compositions
03/01/1989	CN1031378A Antibiotic compounds
03/01/1989	CN1031374A Process for preparing 1.5-benzothiazepine derivatives
02/1989
02/22/1989	EP0304158A1 Cephalosporins, processes for their preparation and pharmaceutical compositions containing them
02/22/1989	EP0304036A2 3-(substituted)propenyl-7-(aminothiazolylacetamido)ceph-3-em-4-carboxylic acids and esters thereof
02/22/1989	EP0303697A1 Derivatives of physiologically active substance k-252
02/22/1989	CN1031229A Process for preporing 1.5-benzothiazepine eerivatives
02/22/1989	CN1031184A Medicated compound as well as its pren. and application
02/21/1989	US4806550 4-Amino-3-carbonyl substituted quinolines as inhibitors of gastric acid secretion
02/21/1989	US4806549 4-amino-3-carbonyl substituted quinolines
02/21/1989	CA1250294A1 Antihypertensive chroman derivatives
02/15/1989	CN1031085A Method for preparing crystalline cefadroxil monoltydrate
02/08/1989	EP0302145A2 Method for preparing crystalline cefadroxil monohydrate
02/01/1989	CN1030760A New method for prepg. cephalkenes and new ceplalosporin derivatives

1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 105